Hungary and Russia are in advanced talks on licensing production of the Russian Sputnik V COVID-19 vaccine in Hungary, Reuters news agency reported on Tuesday.
Production under the deal could start from the end of 2022, Hungary's foreign minister said.
Hungary has widely used the Russian Sputnik vaccine during the pandemic even though it has not been approved by the European Medicines Agency.
hVIVO secures GBP11.5m RSV contract
Novavax sells Czech manufacturing site to Novo Nordisk for USD200m
Valneva reports strong, long-lasting immunity from single-dose chikungunya vaccine
Scancell reports promising SCOPE trial data for SCIB1 in advanced melanoma
Transgene teams up with ProBioGen for individualised cancer vaccines
Bio-Works Technologies AB secures LOI for vaccine manufacturing product
LakeShore Biopharma's Phase III YSJA Rabies Vaccine clinical trial receives Chinese NMPA approval